Combined Modality Therapy for Lymph Node Positive Prostate Cancer
Historically, the management of lymph node positive prostate cancer was limited to androgen deprivation therapy, but increasing data now support the use of multimodality therapy. As treatment options have expanded, patient-centered decision making has become increasingly complicated.
Category
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Challenging Cases in GI Malignancies - Caring for GI Cancer Patients Across All Practice Settings
This activity presents challenging clinical scenarios arising in the management of patients with gastrointestinal malignancies.
Category
  • Gastrointestinal
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Innovative Radiation Therapy Approaches: Benefits & Challenges - Global Perspective
MRI-guided Radiation Therapy (MRgRT), FLASH proton therapy, concurrent immunotherapy, and radiation therapy and SBRT for oligometastatic disease, are emerging technologies and approaches to optimize cancer care.
Category
  • FLASH RT
  • General RO
  • Immunotherapy
  • SBRT
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Evolving Paradigms in Prostate Cancer: The Integral Role of PSMA PET/CT in Primary Staging and Therapeutic Decision-Making
The incidence of prostate cancer is increasing, with most diagnosed with localized disease. Appropriate staging is crucial to ensure optimal treatments are delivered.
Category
  • Genitourinary
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
Cost $49.00
Update on ASTRO's Partial Breast Irradiation Guidelines: Case-based Discussion
Breast cancer is the most diagnosed cancer in women. The most commonly diagnosed form of breast cancer in the United States is early-stage breast cancer, for which there are outstanding outcomes.
Category
  • Breast
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Pitfalls, Perils and Pearls: Identifying and Managing Gynecologic Treatment Toxicity
The introduction of novel therapies for gynecologic malignancies such as immunotherapy, SBRT and complex brachytherapy can lead to increased frequency of severe toxicities for which treatment options may be limited.
Category
  • Brachytherapy
  • Gynecologic
  • Immunotherapy
  • SBRT
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
How Sentinel Lymph Node Biopsy is Impacting Adjuvant Radiation Treatment in Gynecologic Cancers
There is increasing use of sentinel lymph node biopsy in gynecologic cancers but how best to integrate this information into post-operative radiation treatment recommendations is not always clear. This includes how to interpret isolated tumor cells, micrometastasis, and macrometastasis.
Category
  • Gynecologic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Hypofractionation for Soft Tissue Sarcoma
Modern trends throughout radiation oncology have favored short-course hypofractionated regimens which are frequently more cost-effective and convenient for patients. Over the past two years, multiple prospective studies have emerged supporting hypofractionation in soft tissue sarcoma.
Category
  • Hypofractionation
  • Sarcoma
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Collaborative Approaches for Challenging CNS Cases: Neurosurgeons and Radiation Oncologists in Practice
This joint session was developed between the American Society for Radiation Oncology (ASTRO) and the American Association of Neurological Surgeons (AANS).
Category
  • Central Nervous System
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Beyond Counting on Our Fingers: The Current State and Future Management of Oligometastatic Lung Cancer
There is a high degree of variability in the management and even the understanding of the oligometastatic state in lung malignancies, or indeed in the context of any solid tumor.
Category
  • Oligometastatic
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00

Pages